Patrick Rivelli is a eficient expert, that works in Savran Technologies on the position of President and Chief Executive Officer since 2017. This person has earned professional experience in more than 12 positions at various companies. Patrick Rivelli went to the Mit Sloan School of Management and received education there from 1989 to 1991. Boston, Massachusetts is the area, where this professional was lastly known to live. Patrick's phone and email can be easily accessed through this website by request.
Name variants:
Pat Rivelli,
Paddy Rivelli,
Patsy Rivelli,
Rick Rivelli
Last updated Jun 08, 2024
Contact Information
Last Update
Jun 27, 2022
Location
Boston, MA
Company
Savran Technologies
Workplace
President and Chief Executive Officer
Work History
President and Chief Executive Officer
Non-invasive diagnostics based on capture and analysis of rare cells. Initial applications in oncology, immuno-oncology, and pre-natal.
Sep 2017 — Nov 2018
President and Chief Executive Officer
Liquid biopsy technology focusing on ultra-gentle, label-free capture of circulating tumor cells and sub-cellular bodies. Initial focus in oncology -- diagnosis and treatment monitoring.
Aug 2016 — Sep 2017
President and Chief Executive Officer
Clinical-stage medical device company working in prevention and treatment of kidney disease.
Jan 2012 — Aug 2016
Director, Life Sciences Track
Our group provides seed-stage financing to MIT-pedigreed companies in the life sciences sector. Areas of focus include drug discovery, drug delivery, medical devices, diagnostics, genomics, ...
from Jun 2016
Deputy Director and Life Sciences Track Lead
Our group provides seed-stage financing to MIT-pedigreed companies in deep sciences / technology sectors, including life sciences. Investment / Director positions include: 6 Sensor Labs
Mi...
from Jan 2015
President and Chief Executive Officer
Menlo Park, CA
Fully bioabsorbable polymeric drug-eluting stents for coronary and peripheral artery disease. Acquired by Multi Cell Corporation.
Apr 2004 — Nov 2009
Angel and Seed-Stage Investor
Investment / Director positions included C2 Therapeutics (acquired by Pentax)
Lyric Pharmaceuticals
and Rodo Medical.
Sep 2002 — Apr 2004
President and Chief Executive Officer
Stents for neuro-vascular disease -- intracranial aneurysms (Neuroform stent) and intracranial atherosclerosis (Wingspan stent). Acquired by Boston Scientific.
Jun 1998 — Sep 2002
Vp, Business Development and Marketing
Stents for carotid artery disease. Acquired by Boston Scientific.
Jun 1997 — Jun 1998
Vice President of Strategic Planning and Manufacturing
Medical devices for treating neuro-vascular disease. Acquired by Boston Scientific.
Jan 1996 — Jun 1997
Vice President, Integral Management Consulting
111 Huntington Ave, Boston, MA 02199
Apr 1992 — Jan 1996
Education
1989 — 1991
1982 — 1986
Occupations
Executive
Director
Chief Executive Officer
Chairperson
Doctor
Oncologist
Scientist
Biotechnology Professional
Operations Manager
Corporate Executive
Chief Executive
Medical Practice Professional
Medical Practitioner
Biologist
Biological Scientist
Skills
Business Development
Start Ups
Medical Devices
Strategic Planning
Entrepreneurship
Venture Capital
Product Development
Strategy
Fda
R&D
Angel Investing
FAQs about Patrick Rivelli
What's the main profession of Patrick Rivelli?
Patrick Rivelli is a Director, Life Sciences Track.
What are the profession of The professional?
These person's professions are Executive and Director
Where does Patrick Rivelli currently live?
They lives in Boston, Massachusetts.
How many companies did Patrick Rivelli work at?
The professional worked at 12 jobs.
What education does Patrick Rivelli have?
Patrick studied at the Mit Sloan School of Management from 1989 to 1991.
Are there any special industries Patrick Rivelli works in?
Patrick Rivelli works in Biotechnology industry.
Are there any special skills Patrick Rivelli has?
Patrick Rivelli has the following skills: Business Development, Start Ups, Medical Devices, Strategic Planning, Entrepreneurship, Venture Capital, Product Development, Strategy, Fda, and R&D.